1,534
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Predialysis nephrology care amongst Palestinian hemodialysis patients and its impact on initial vascular access type

, , &
Pages 200-206 | Received 28 Oct 2019, Accepted 30 Jan 2020, Published online: 18 Feb 2020

References

  • Fischer MJ, Stroupe KT, Kaufman JS, et al. Predialysis nephrology care and dialysis-related health outcomes among older adults initiating dialysis. BMC Nephrol. 2016;17:103.
  • Agency for Healthcare Research and Quality. Chartbook on effective treatment of chronic kidney disease; 2018. Available from: https://www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/kidney.html
  • Smart NA, Dieberg G, Ladhani M, et al. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014:CD007333.
  • Mahmood SN, Mukhtar KN, Iqbal N, et al. Pre dialysis care and types of vascular access employed in incident hemodialysis patients: a study from Pakistan. Pak J Med Sci. 2013;29:828–831.
  • Gillespie BW, Morgenstern H, Hedgeman E, et al. Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J. 2015;8:772–780.
  • Kukita K, Ohira S, Amano I, et al. 2011 Update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis. Ther Apher Dial. 2015;19:1–39.
  • Navuluri R, Regalado S. The KDOQI 2006 Vascular Access Update and Fistula First Program Synopsis. Semin Intervent Radiol. 2009;26:122–124.
  • Tordoir J, Canaud B, Haage P, et al. EBPG on vascular access. Nephrol Dial Transplant. 2007;22:ii88–ii117.
  • Polkinghorne KR, Chin GK, MacGinley RJ, et al. KHA-CARI Guideline: vascular access – central venous catheters, arteriovenous fistulae and arteriovenous grafts. Nephrology (Carlton). 2013;18:701–705.
  • Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60:1443–1451.
  • Ishani A, Collins AJ, Herzog CA, et al. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int. 2005;68:311–318.
  • Lacson E, Wang W, Hakim RM Jr, et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis. 2009;53:79–90.
  • Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449–1455.
  • Banerjee T, Kim SJ, Astor B, et al. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014;64:954–961.
  • Polkinghorne KR, McDonald SP, Atkins RC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15:477–486.
  • United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017.
  • Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–1053.
  • Lee T. Fistula first initiative: historical impact on vascular access practice patterns and influence on future vascular access care. Cardiovasc Eng Technol. 2017;8:244–254.
  • Donca IZ, Wish JB. Systemic barriers to optimal hemodialysis access. Semin Nephrol. 2012;32:519–529.
  • Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial. 2003;16:189–196.
  • United States Renal Data System. Healthy people 2020; 2018. Available from: https://www.usrds.org/2018/view/HP2020.aspx
  • Ministry of Health, Palestinian Health Information Center. Health annual report, Palestine 2016; 2017 [cited 2018 Jan 20]. Available from: http://www.site.moh.ps/Content/Books/ZxRcynmiUofNqt66u4CrHRgmJR6Uv7z77srjjIEAho6xnz5V3rgLTu_RhO7xf2j2VusNiIvWkjwp84yXHLdGleB97gKrHHI5iZ9oPJ25owGEN.pdf
  • Ministry of Health, Palestinian Health Information Center. Health annual report, Palestine 2015; 2016 [cited 2017 Feb 17]. Available from: http://site.moh.ps/Content/Books/NWNJXX7RJ92Bn4f5EGYiH43a2tjAAzKBnseGnEUCaqWqYZndsbCcPy_JQWguvkHTR4Xk4zUpdT45ooWxH11BhIbVAxwpGWy2wiwHdGcM5K7aZ.pdf
  • Hamadneh SA, Nueirat SA, Qadoomi’ J, et al. Vascular access mortality and hospitalization among hemodialysis patients in Palestine. Saudi J Kidney Dis Transpl. 2018;29:120–126.
  • Hamdan Z, As’ad N, Sawalmeh O, et al. Vascular access types in hemodialysis patients in Palestine and factors affecting their distribution: a cross-sectional study. Saudi J Kidney Dis Transpl. 2019;30:166–174.
  • Khatib ST, Hemadneh MK, Hasan SA, et al. Quality of life in hemodialysis diabetic patients: a multicenter cross-sectional study from Palestine. BMC Nephrol. 2018;19:49.
  • Khader MI, Snouber S, Alkhatib A, et al. Prevalence of patients with end-stage renal disease on dialysis in the West Bank, Palestine. Saudi J Kidney Dis Transpl. 2013;24:832–837.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–735.
  • Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48:S2–S90.
  • Lee J, Lee JP, An JN, et al. Factors affecting the referral time to nephrologists in patients with chronic kidney disease: a prospective cohort study in Korea. Medicine (Baltimore). 2016;95:e3648.
  • Lameire N, Wauters JP, Teruel JL, et al. An update on the referral pattern of patients with end-stage renal disease. Kidney Int Suppl. 2002;80:27–34.
  • NKF-KDOQI. Clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2001;37:S137–S181.
  • Ethier JE, Lindsay RM, Barre PE, et al. Clinical practice guidelines for vascular access. J Am Soc Nephrol. 1999;10:S297–S305.
  • NKF-KDOQI. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48:S248–S272.
  • Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7:523–535.
  • Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39:92–101.
  • Huber TS, Carter JW, Carter RL, et al. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38:1005–1011.
  • Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61:305–316.
  • Hoen B, Kessler M, Hestin D, et al. Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant. 1995;10:377–381.
  • Combe C, Pisoni RL, Port FK, et al. Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis. Néphrologie. 2001;22:379–384.
  • Foley RN, Chen SC, Collins AJ. Hemodialysis access at initiation in the United States, 2005 to 2007: still “catheter first”. Hemodial Int. 2009;13:533–542.
  • Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001;38:494–501.
  • Navaneethan SD, Nigwekar S, Sengodan M, et al. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007;106:c113–c118.
  • Chan MR, Dall AT, Fletcher KE, et al. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120:1063–1070.
  • Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310–318.
  • Okazaki M, Inaguma D, Imaizumi T, et al. Unfavorable effects of history of volume overload and late referral to a nephrologist on mortality in patients initiating dialysis: a multicenter prospective cohort study in Japan. BMC Nephrol. 2018;19:65.
  • Hommel K, Madsen M, Kamper AL. The importance of early referral for the treatment of chronic kidney disease: a Danish Nationwide Cohort Study. BMC Nephrol. 2012;13:108.
  • Schmidt RJ, Domico JR, Sorkin MI, et al. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis. 1998;32:278–283.
  • Heatley SA. Optimal referral to pre-dialysis services: one center’s experience. Perit Dial Int. 2009;29:115–116.
  • Lee J, Lee JP, Park JI, et al. Early nephrology referral reduces the economic costs among patients who start renal replacement therapy: a prospective cohort study in Korea. PLoS One. 2014;9:e99460.
  • Minutolo R, Lapi F, Chiodini P, et al. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study. Clin J Am Soc Nephrol. 2014;9:1586–1593.
  • Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14:1–184.
  • Selim G, Stojceva-Taneva O, Polenakovic M, et al. Effect of nephrology referral on the initiation of haemodialysis and mortality in ESRD patients. Prilozi. 2007;28:111–126.
  • Lopez-Vargas PA, Craig JC, Gallagher MP, et al. Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis. 2011;57:873–882.
  • Vassalotti JA, Jennings WC, Beathard GA, et al. Fistula First Breakthrough Initiative: targeting catheter last in fistula first. Semin Dial. 2012;25:303–310.
  • Erickson KF, Mell MW, Winkelmayer WC, et al. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015;10:269–277.